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While the cornerstone of monitoring following severe pediatric traumatic brain injury is serial neurologic examinations, vital
signs, and intracranial pressure monitoring, additional techniques may provide useful insight into early detection of evolving
brain injury. This paper provides an overview of recent advances in neuromonitoring, neuroimaging, and biomarker analysis of
pediatric patients following traumatic brain injury.
1.Introduction
Pediatric traumatic brain injury (TBI) remains one of the
leading causes of acquired disability and death, with the
highest combined rates of TBI-related emergency room
visits, hospitalizations, and deaths occurring in the youngest
children [1]. Monitoring intracranial pressure (ICP) and
cerebral perfusion pressure (CPP), repeat neurological as-
sessments, CT scanning, and vital signs are considered the
standard part of care following severe pediatric TBI. How-
ever, these assessments may not be suﬃc i e n tt od e t e c ts u b t l e
and early secondary insults to the brain, such as ischemia,
cerebral cytotoxic or vasogenic edema, and metabolic crisis.
With the advent of newer methods of neuromonitoring,
neuroimaging, and biomarker development, the concept of
advanced neuromonitoring in neurocritical care has evolved
inadultsfollowingsevereTBIandisbeginningtobeexplored
in children. In this paper, we will discuss the role of advanced
neuromonitoring in children following TBI.
2.MaterialsandMethods
We performed an extensive review of the medical literature
regarding advanced neuromonitoring in children following
TBI utilizing Pubmed. Search terms included “pediatric,”
“child,” “neonate,” “brain,” “traumatic brain injury,” “mul-
timodality,” “monitoring,” “brain oxygen,” “licox,” “jugular
venous saturation,” “microdialysis,” “transcranial doppler,”
“neuroimaging,” “diﬀusion weighted imaging,” “susceptibil-
ity weighted imaging,” “diﬀusion tensor imaging,” “ mag-
netic resonance spectroscopy,” “biospecimen,” “biomarker,”
“common data elements,” “S100B,” “neuron speciﬁc eno-
lase,” “myelin basic protein,” and “glial ﬁbrillary acidic pro-
tein,” and the period of search was from 1987 to 2011.
The authors are pediatric neurocritical care specialists
and have extensive clinical experience caring for pediatric
patients with TBI and research experience in clinical pedi-
atric TBI and experimental animal models of pediatric
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3. Results andDiscussion
3.1. Neuromonitoring following Severe TBI in Children
3.1.1. Brain Tissue Oxygen Monitoring. One of the primary
management goals of the severely head injured child is to
minimize secondary injury. One of the leading causes of sec-
ondaryinjuryiscerebralischemiaandhypoxia[2].Detecting
cerebral ischemia with real-time continuous monitoring has
proven to be elusive. Adherence to ICP- and CPP-driven
management protocols does not guarantee the avoidance of
cerebral ischemia or hypoxia [3, 4]. Cerebral blood (CBF)
ﬂow threshold for cerebral ischemia in the nontraumatized
brain has been reported at 18mL/100g/min, and, when
CBF falls below 10mL/100g/min, cerebral infarction occurs
[5, 6]. In TBI, it appears the relationship between CBF and
brain metabolism is much more complex. Injured tissues
may have reduced metabolic needs due to cellular injury
and/or mitochondrial dysfunction in which case lower CBF
levels may be appropriate or tissues may be hypermetabolic
and normal CBF levels may still result in secondary injury.
The ability to measure adequacy of brain oxygen delivery
and utilization can assist the clinician in managing the
severe pediatric TBI patient to minimize the magnitude of
secondary injury. The two most common methods utilized
to assess brain oxygenation are brain tissue oxygen tension
and jugular venous saturation monitoring, each with various
strength and weaknesses.
3.1.2. Brain Tissue Oxygen Tension Monitoring. Brain tissue
oxygen tension (PbtO2) monitoring has been utilized by
clinicians to guide medical management of both adult and
pediatric severely head injured patients. The most com-
monly used commercially available system is the Licox
system (Licox, Integra Life Sciences, Plainsboro, NJ). A
polarographic electrode catheter is inserted into the brain
parenchyma of the region of interest using a specially
designed bolt system. Oxygen diﬀuses across the catheter
membrane and generates a voltage which is proportional
to the amount of oxygen at the electrode site. The voltage-
oxygen relationship is temperature dependent, and brain
parenchymal temperature must be continuously monitored
at the electrode site for accurate PbtO2 measurements. A
c o m b i n e do x y g e ne l e c t r o d ea n dt e m p e r a t u r ep r o b eh a sb e e n
developed to reduce the number of ports required in the
bolt system [7]. The probe surface area is approximately 1–
15mm2, so that information obtained represents only a very
small region of brain parenchyma. This emphasizes the need
for conﬁrmation of probe location. Typically after insertion,
an oxygen challenge is performed, inspired fraction of oxy-
gen is temporarily increased to 100%, and a subsequent rise
in PbtO2 should be observed [4, 8]. Computed tomography
(CT) of the head can also be performed to assess probe
location, but this need must be weighed with the risk of
repeated radiation exposure to the pediatric patient [9].
What the PbtO2 value physiologically represents is not
completely clear and is still under investigation. In clinical
studies,PbtO2 hasbeenobservedtovarywitharterialoxygen
tension as well as factors that aﬀect CBF (such as arterial
CO2 and cerebral perfusion pressure) [10–14]. Most likely,
PbtO2 reﬂects the accumulation of oxygen in the brain
parenchyma which is directly inﬂuenced by three factors:
oxygen delivery, oxygen diﬀusion characteristics of the
region of interest, and oxygen utilization by the brain tissue.
Clinical studies have yet to establish normal and threshold
values of PbtO2 for adults or children. Extrapolating from
animal studies, normal PbtO2 values of 20–30mmHg are
consistent with what has been observed in regions of
uninjured brain clinically [15–17]. A threshold of 10mmHg
has been associated with ischemic CBF levels, mitochondrial
dysfunction, and derangements in cerebral metabolism as
measured by microdialysis [6]. A persistent PbtO2 value of
0mmHg has been associated with brain death in several case
series of both adults and children [18, 19]. PbtO2 values in
the 10–20mmHg range may represent brain tissue at risk for
secondary injury and may prompt the clinician to intervene.
TheassociationofPbtO2 <10mmHgandpooroutcome
in TBI has been well documented in adults, but it remains
unclear if PbtO2-directed management improves outcome
[20–23]. Several adult studies have demonstrated improved
outcomes following PbtO2-directed therapies compared to
historical controls [24–26]. The ﬁrst reported use of PbtO2-
monitoring in children with TBI was a case series of six
children reported in 2006 [27]. Since then there have been
multiplereportsofitsuseinpediatricTBI,butunfortunately
it remains unclear if PbtO2-directed therapy improves
outcome [3, 28, 29]. Some of the challenges in attempting to
study the eﬃcacy of PbtO2-monitoring include patient pop-
ulation and heterogeneity, the Hawthorne eﬀect when using
historical controls, and variations in interventions utilized
in response to low PbtO2. Several reports on interventions
to increase PbtO2 in children with TBI have recently been
published [10, 30]. The eﬀects of increasing arterial oxygen
content and carrying capacity on PbtO2 have been evaluated
in children with severe TBI [30]. Blood transfusions were
observed to transiently increase PbtO2 in 17 children, but
PbtO2 returnedtobaselinewithin24hrs.Normobarichyper-
oxia challenges for 15 minutes in 28 children were observed
to increase PbtO2,a n dam o r er o b u s tr e s p o n s ew a so b s e r v e d
to be associated with poorer outcome [10], but it remains
unknown if normobaric hyperoxia should be instituted due
to the concerns that an abundance of oxygen may result in
increased free radical production and worsening secondary
injury [31]. Due to the paucity of strong evidence for PbtO2
monitoringinpediatricTBI,themostrecentconsensuspedi-
atricTBIguidelinescouldonlymakealevelIIIrecommenda-
tiontoconsidermaintainingaPbtO2 ≥10mmHgifPbtO2 is
used [32]. In summary, interpretation of PbtO2 monitoring
inTBIremainscomplex,andeﬀectiveandeﬃcaciousPbtO2-
driven management protocols have yet to be established.
3.1.3. Jugular Venous Saturation Monitoring. Jugular venous
saturation monitoring (SjvO2) is another method utilized to
detect secondary insults following severe TBI. A catheter is
inserted retrogradely to the jugular venous bulb. Catheter
placement is conﬁrmed with skull radiograph, with proper
positioning demonstrating the catheter tip above the level
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bloodsamplesorbyutilizingaﬁberopticcathetertocalculate
jugular venous oxygen saturation. The incidence of com-
plications associated with SjvO2 monitoring is low but can
include bleeding, unintentional arterial puncture, thrombus
formation, and infection.
SjvO2 monitoring measures the balance between oxygen
supply and demand. Factors aﬀecting oxygen supply include
oxygen carrying capacity, arterial oxygen content, oxygen-
hemoglobin dissociation at the capillary level and CBF. Oxy-
gen demand is primarily inﬂuenced by cerebral metabolic
rate of oxygen (CMRO2). Increases in SjvO2 may reﬂect
rises in CBF, reduced diﬀusion of oxygen into the tissues, or
reduced CMRO2. Similarly, decreases in SjvO2 may be the
result of cerebral hypoperfusion, decreased arterial oxygen
content or carrying capacity, or increased CMRO2.T h e
normal accepted range for SjvO2 in adults is 50–75%, but
consensus thresholds for children have not been established.
SjvO2 values below 50% in adult TBI patients have been
associated with poor outcome [34], while SjvO2 values above
75% have also been observed to have a negative eﬀect on
outcome [35].
The pediatric literature for the use of SjvO2 monitoring
in children with TBI is quite limited. P´ erez et al. reported
theirexperiencewith27childrenwithsevereTBIwhounder-
went SjvO2 monitoring [36]. They observed a signiﬁcant
association of two or more episodes of SjvO2 below 50%
with poor outcome. However, SjvO2 values greater than 70%
were not associated with poor outcome. There are several
challenges and limitations to SjvO2 monitoring. Catheter
location may vary with head positioning, catheter size may
impede its use in younger children, and the development
of thrombi can require frequent recalibration. In summary,
the pediatric experience with SjvO2 monitoring is limited,
normal ranges and SjvO2 thresholds for children have yet
to be established and similar to PbtO2 monitoring, and the
eﬃcacy of SjvO2 driven management protocols has not been
established.
3.1.4. Cerebral Microdialysis. Cerebral microdialysis is a
neuromonitoring technique which has primarily been uti-
lized as an invaluable research tool but holds potential to
improve the care of the pediatric TBI patient. The technique
involves the insertion of a semipermeable membrane tipped
catheter into the brain parenchyma. The catheter is then
infused with a dialysate at a low continuous rate (typically 1
microliter/min). Small molecules diﬀuse across the semiper-
meable membrane from the brain interstitial ﬂuid into the
dialysate. Samples can be collected at desired intervals and
analyzed for various substances including markers of cell
metabolism (lactate, pyruvate, glucose), neurotransmitters
(glutamate), or markers of tissue damage (glycerol). The
catheter membranes can have various molecular size cutoﬀs
ranging from 20 to 100kDa. Normal values for several
small molecules have been established in adults [37]. Small
adult studies have observed sustained elevations in the
lactate/pyruvate ratios in pericontusional brain tissue [38].
Elevated brain tissue glycerol levels have also been observed
to be associated with poor outcome following severe TBI
in adults [39, 40]. A consensus published on microdialysis
in adults recommended the use of lactate/pyruvate ratios,
glucose, glycerol, and glutamate as markers for the detection
of ischemia following TBI [41].
The ﬁrst use of microdialysis in children with TBI was
a case series of nine children in 2002 and focused on the
levels of neurotransmitter amino acids (glutamate) as well
asnonneurotransmitteraminoacids(threonine,tryptophan,
lysine, and tyrosine) [42]. Although a small sample size,
the authors reported diﬀerences in the levels of excitatory
neurotransmitters compared to previous reports in adults.
This observation highlights the need to explore whether the
changesinbraindevelopment(suchasongoingmyelination)
may result in variations in normal ranges and critical
thresholds of microdialysis in pediatric TBI compared to
adults. In summary, cerebral microdialysis is an exciting
research tool which has not yet demonstrated proven beneﬁt
in the management of children with severe TBI.
3.1.5. Transcranial Doppler Ultrasonography. Transcranial
doppler ultrasonography (TCD) is a bedside test utilized to
measure cerebral blood ﬂow velocity typically of the middle
cerebral artery. Accuracy of the method can be user depen-
dent, and interobserver reliability can be variable. Cerebral
blood ﬂow velocities vary with age, and these changes corre-
late well with age-dependent changes in CBF [43]. TCD has
been utilized as a noninvasive method to estimate CPP and
ICP. Utilizing a pulsatility index (PI) under the assumption
of stable blood pressure and arterial CO2 content, strong
correlations have been observed between PI and elevations
in ICP [44–47]. While pediatric TBI experience with PI is
not as robust, several recent studies of 34 children with
severe TBI revealed a poor correlation of between PI and ICP
[48,49].TCDcanalsobeusedtodiagnosecerebralvasopasm
whichappearstobemorecommoninadultTBIcomparedto
children [49–51].
Morerecently,TCDhasbeenutilizedtoevaluatethepres-
ence or absence of pressure autoregulation (AR). Cerebral
pressure autoregulation is the physiologic response in which
the diameter of cerebral blood vessels varies with changes
in systemic blood pressure to ensure a constant CBF. As
mean arterial pressure (MAP) rises, cerebral blood vessels
(typicallythearterioles)constrict,and,asmeanarterialpres-
sure decreases, cerebral blood vessels dilate. This pressure
reactivity is thought to remain intact over a range of MAP
from 50 to 150mmHg in the adult uninjured brain [52]. An
autoregulation index (ARI) has been developed to measure
if the autoregulation response is intact by the following
equation: ARI = %ΔeCVR/%ΔMAP, where the estimated
cerebrovascular resistance (eCVR) is calculated by the ratio
ofMAPtocerebralbloodﬂowvelocitymeasuredbyTCD.An
ARI value ≥ 0.4 is typically considered intact autoregulation.
Autoregulation has been observed to be impaired in up to
two-thirds of adults and 40% of children with severe TBI
[53–56]. Impairment in autoregulation has been observed to
be associated with poor outcome in adult and pediatric TBI
patients, but it remains unclear if impaired autoregulation is
an independent risk factor for poor outcome [57–59].4 Critical Care Research and Practice
3.2. Neuroimaging following TBI in Children
3.2.1. Diﬀusion Weighted Imaging. While CT scanning may
still be the fastest way to evaluate for acute life-threatening
intracranial emergencies following pediatric TBI, there has
beenatremendousadvancementindiﬀerentMRItechniques
to better characterize speciﬁc details of the injured brain.
Importantly,thesediﬀerentMRImodesdetectaspectsofTBI
that may not be detected by CT or conventional MRI. One of
these MRI techniques is diﬀusion weighted imaging (DWI).
Images on DWI are sensitive to diﬀerences in the diﬀusion
rate of water molecules and can detect vasogenic and
cytotoxicedema.Increased diﬀusionisthoughttooccurwith
vasogenic edema due to increased water in the extracellular
space where there is increased mobility, while restricted dif-
fusion due to decreased water movement in the intracellular
space is thought to be due to cytotoxic edema [60].
DWI also can quantify water mobility by determining
apparent diﬀusion coeﬃcient (ADC) values, a measure of
random water motion limited by cellular composition. ADC
measurements are useful in detecting diﬀuse axonal injury
(DAI) in pediatric TBI patients. Before DWI, it was diﬃcult
to detect axonal ischemia or damage in the pediatric brain
due to the relatively high water content of the developing
w h i t em a t t e rt r a c t s .D W Ia l l o w si m p r o v e dd i ﬀerentiation
between the uninjured immature brain and injured area
b e c a u s et h ei m m a t u r ew h i t em a t t e rt r a c t sh a v el e s sw a t e r
restriction than mature brain or hyperintense ADC values
compared to the adult brain, while injured brain regions
usually have increased water restriction or hypointense ADC
values relative to the uninjured immature brain [61].
While there are numerous studies of DWI and ADC for
lesion detection and outcome following TBI in adults, less
is known about DWI and ADC in pediatric TBI. In one
recent study, ADC values (obtained within 7 days of injury)
in the peripheral white matter tracts were signiﬁcantly
reduced in children with severe TBI that had poor outcomes
compared to children with severe TBI that had good
outcomes at 6–12 months after trauma [62]. Furthermore,
acute ADC values in the peripheral white and gray matter
regions following pediatric TBI were inversely correlated
with long-term (1–4 years) neurocognitive outcomes [63].
DWI has also been shown to allow earlier detection of acute
cerebral ischemia than conventional CT or MRI as processes
associated with ischemic injury result in greater diﬀusion
restriction [61, 64]. This may be especially important in
cases of suspected abusive pediatric TBI or nonaccidental
trauma (NAT). Several studies have revealed that DWI and
ADCdetectedlesionsearlierandmoreextensivebraininjury,
especially ischemic lesions and lesions in the white matter
tracts, than conventional MRI or demonstrated lesions
when conventional MRI appeared normal in children with
suspected NAT [61, 65–71].
3.2.2. Susceptibility Weighted Imaging. In pediatric TBI,
hemorrhagic shearing lesions associated with DAI are a
very common pathologic entity [72]. Unlike the large hem-
orrhages seen in contusions, epidural and subdural hem-
atomas, conventional CT or MRI will usually not pick up
these small shearing hemorrhagic lesions. Susceptibility
weighted imaging (SWI) is a form of MRI that utilizes the
paramagnetic properties of blood products (intravascular
and extravascular deoxyhemoglobin, methemoglobin, and
hemosiderin) based on their magnetic susceptibility eﬀects
inordertoincreasethevisibilityofmicroscopichemorrhages
[73, 74]. SWI has been shown to be superior in detecting
hemorrhagic DAI after TBI in children compared to con-
ventional MRI [75, 76]. In another study in children with
TBI and DAI, the patients with lower initial Glasgow Coma
Scale (GCS) or prolonged coma had a signiﬁcantly increased
average number and volume of hemorrhagic DAI lesions
[77]. Furthermore, children who had worse outcome at 6–12
months after injury had signiﬁcantly increased extent of
hemorrhagic DAI lesions [77]. Recently, the increased extent
of hemorrhagic DAI was associated with worse intelligence
quotient (IQ) and neuropsychologic functioning in children
and adolescents at 1–4 years after trauma [78].
SWI may also prove valuable in the assessment of chil-
dren with NAT. In a recent study, the presence of intra-
parenchymal brain microhemorrhages in infants with NAT
using SWI was associated with worse initial GCS and
poor outcome at 6 or more months than children with-
out microhemorrhages [79]. Furthermore, the presence of
microhemorrhages on SWI combined with evidence of
ischemia on DWI was the most predictive of poor outcome
while other radiological ﬁndings (extra-axial hemorrhages,
skull or skeletal fractures) were not [79].
3.2.3. Diﬀusion Tensor Imaging. Another novel modality in
MRI involves the use of diﬀusion tensor imaging (DTI),
which is a more complex form of DWI. DTI takes advantage
of the directionality of water diﬀusion in the human brain
a n da l l o w sa n a l y s i so ft h ew h i t em a t t e rt r a c t s[ 80, 81]. Water
diﬀusion is considered isotropic when motion is free and
equal in all directions. In the normal brain tissue, there
are physical boundaries that restrict water diﬀusion in the
white matter tracts, with greater water mobility parallel
to the axons and restriction of mobility perpendicular to
the axons. This diﬀusion restriction is termed fractional
anisotropy (FA) or the ratio of anisotropy to isotropy [82];
FA ranges from 0 to 1, where values closer to 0 represent
isotropy or increased diﬀusion, for example, as a result of
injury [83]. In contrast, values closer to 1 represent water
diﬀusion more parallel to the white matter tracts in normal
brain tissue. Water diﬀusion by isotropy is also measured
by ADC [84, 85]. Although the association between FA
and ADC in the white matter tracts are very complex and
incompletely understood, in general FA is inversely related
to ADC. Typically, higher FA and lower ADC values are
associated with intact white matter tracts.
Pediatric DTI studies done within weeks to years after
TBI generally reveal reduced FA. In one study, FA was
reduced in the corpus callosum (CC) in TBI patients
compared to control patients; FA values were also lower with
more severe injuries (GCS < 10 and positive MRI ﬁndings)
than those with milder injuries (GCS > 10 and normal
MRI ﬁndings) [86]. Another study revealed reduced FA andCritical Care Research and Practice 5
increased ADC in the white matter tracts of the TBI group
compared to controls [87] and correlated with cognitive
and global outcome [88]. Several studies revealed that DTI
studies performed at a mean of 3 years after trauma revealed
lower FA in the isthmus, genu, body and splenium of the
CC; those that had higher FA values had better cognitive
function and global outcome [89, 90]. Other studies revealed
reduced FA following trauma in various white matter tracts
[91–93] and associated with working memory and executive
deﬁcits [92, 93]. A diﬀerent study revealed that the initial
injury severity, as assessed by GCS, correlated with changes
in the FA in the white matter tracts even at a minimum
of 1 year after TBI [94]. In contrast, DTI studies obtained
within 1 week after mild pediatric TBI had increased FA and
decreased ADC suggestive of cytotoxic edema, compared to
controls [95–97]. These DTI abnormalities were associated
with more emotional distress, postconcussive symptoms and
30-minute delayed recall [95–97].
3.2.4.MagneticResonanceSpectroscopy. Anotherneuroimag-
ingtechniquethatallowsnoninvasiveanalysisofneurochem-
icals and their metabolites in the brain involves magnetic
resonance spectroscopy (MRS). While MRI uses signals
from the proton nuclei of water to reconstruct anatomical
images, MRS uses the protons located on neurochemicals
within brain tissues. Several key brain metabolites measured
by MRS include N-acetylaspartate (NAA), an amino acid
synthesized in the mitochondria, that is a neuronal and
axonal marker that decreases with neuronal dysfunction or
loss [98]. Total creatine (Cr) composed of phosphocreatine
and its precursor Cr are markers of intact brain energy
metabolism. Total choline (Cho) which predominantly con-
sists of phosphoryl and glycerophosphoryl Cho is a marker
for membrane repair or synthesis, demyelination, or inﬂam-
mation. Lactate is a result of anaerobic glycolysis and/or may
be a response to release of glutamate [99]. Glutamate and
glutamine are excitatory amino acid neurotransmitters that
are released after TBI and may play a major role in neuronal
death [100]. Myoinositol is an organic osmolyte in astrocytes
and increases with glial proliferation [101].
Several MRS studies have revealed decreases in NAA
ratios suggesting neuronal dysfunction or loss and increased
Cho/Cr suggesting DAI not only in areas of visible injury but
also in “normal-appearing” brain after pediatric TBI [102–
107]. A decrease in NAA in a visibly injured brain is probably
caused by the primary impact, while a decrease in NAA in a
“normal-appearing” brain may suggest DAI and subsequent
Wallerian degeneration [101]. Studies have also revealed
increased lactate, myoinositol, or glutamate/glutamine levels
following pediatric TBI [105, 108, 109]. Some of these
neurometabolite alterations have been found to be predictive
of outcome. Reduced NAA ratios, increased Cho/Cr or
lactate or myoinositol were associated with poor outcomes
6–12 months after injury [105, 108]. Interestingly, increased
glutamate/glutamine levels had no correlation with good or
bad outcome 6–12 months following pediatric TBI [109]; in
part, this may have been due to the fact that most children
with poor outcome were evaluated later than those with
good outcome, potentially beyond the time frame for peak
elevation of these excitatory amino acid neurotransmitters
after injury [109].
Additional studies demonstrated that early MRS pre-
dicted long-term (1–4 years) outcome after pediatric TBI.
One study demonstrated that regional measures of NAA
ratios obtained 1-2 weeks after TBI in children were asso-
ciated with 40% variance in cognitive function obtained
1–4 years after injury [110]. Furthermore, regional NAA
ratios were correlated with attention and executive function
[110]. Another study found a correlation between right
frontal white matter choline/creatine ratio and reaction time
[102]. Another study demonstrated that left frontal white
matter choline and creatine correlated with parental report
of internalizing behavioral problems and medial frontal gray
matter creatine and choline correlated with parental report
of social competence [103].
While these various advanced MRI modalities can
enhance the early evaluation of children following pediatric
TBI, the main disadvantages are the need for transport of a
critically ill patient to the scanner, the length of time it takes,
the ﬁndings are representative of only a “ﬁxed” moment in
time, and the potential problem of MRI compatibility with
certain neuromonitoring devices.
3.3. Biospecimen, Biomarker, and Common Data Elements
3.3.1. Biospecimen and Biomarker. The FDA deﬁnes a bio-
m a r k e ra s ,“ ac h a r a c t e r i s t i ct h a ti so b j e c t i v e l ym e a s u r e d
and evaluated as an indicator of normal biologic processes,
pathogenic processes, or pharmacologic responses to a ther-
apeutic intervention.” Human biospecimens can come from
likely repositories: tissue, cerebral microdialysate, cerebral
spinal ﬂuid (CSF), urine, and blood. These biospecimens
represent a critical resource of molecular data (genes,
proteins, lipids, metabolites, etc.) and form the emerging
ﬁeld of proteomic and metabolomic analyses in pediatric
TBI translational medicine. The study of speciﬁc biomarkers
for proteomic and metabolomics (including the study of
lipids) analyses will allow investigators the ability to identify
and quantify injury, pinpoint cellular location, decipher
molecular mechanisms, and ultimately develop targeted
therapeutic interventions. We will not discuss the study of
genomic biomarkers in pediatric TBI due to global ethical
questions that still need to be further investigated, but
genomic analyses in pediatrics deserve hypothesis-driven
clinical research and dedicated collaboration that is starting
to emerge in adult TBI [111]. In pediatrics, blood is the most
common biospecimen used to study speciﬁc biomarkers in
pediatric TBI due to its relative availability and ease of
collection; however, CSF, urine, and microdialysate have all
been reported. Some of the most well-studied biomarkers in
pediatric TBI are discussed below.
3.3.2. S100 Calcium Binding Protein B (S100B). S100B is the
most extensively studied biomarker in pediatric TBI, and
while the mechanism of release is still unknown, it is likely
that S100B is released by damaged glial cells and may also6 Critical Care Research and Practice
be actively secreted by activated glial cells following brain
injury [112]. Initial studies examining reference ranges for
S100B in children have shown variability with age and sex,
confounding its use in children [113, 114]. However, in one
pediatric TBI study, peak levels of S100B correlated with 6-
month Glasgow Outcomes Scale (GOS) Extended Pediatric
Score with a negative predictive value of 97% combined with
a positive predictive value of 75% [115]. Additional studies
have also shown some correlation with S100B and predictors
of outcome after accidental and inﬂicted pediatric TBI;
however, S100B continues to have limitations that hinder
its acceptance as an isolated biomarker for prognostication
pediatricTBI:itisfound,outsidetheCNS,thereisvariability
in the values depending on the timing of collection and
comorbidities including cardiac arrest [113, 116–120]. As
with other biomarkers prognostication of pediatric TBI out-
comes may be improved with a panel of biomarkers, or com-
bining with other predictors such as neuroimaging [121].
3.3.3.Neuron-SpeciﬁcEnolaseandMyelinBasicProtein. Neu-
ron-speciﬁcenolase(NSE)isreleasedfromneuronspassively
a f t e rc e l l u l a rd e s t r u c t i o n[ 122]. NSE can also be detected
in neuroendocrine cells and certain tumor cells, as well red
blood cells and platelets. Clinical studies investigating levels
o fN S Ea sab i o m a r k e ra f t e rT B Ih a v ef o u n dt h a tN S Ei s
neither sensitive nor speciﬁc for injury severity following
TBI [123]. While NSE has not been proven useful at this
time as a biomarker for prognostication, it has been valuable
to inform molecular mechanisms of injury following brain
injury and help direct translational studies to investigate
neuroprotective targets for secondary injury. NSE biomarker
levels have similar proﬁles in pediatric inﬂicted TBI and
pediatric hypoxic-ischemic brain injury, but not in pediatric
noninﬂicted TBI, with delayed increase in serum levels
suggesting prolonged neuronal death likely due to apoptotic
pathways, and the important role that hypoxic-ischemic
injury may play in child abuse and cardiopulmonary arrest
[113, 124]. Damage to the axon may be measured by myelin
basic protein (MBP), a protein that is found throughout
the white matter tracts of the CNS. Similar to NSE, delayed
increasesinMBPwerealsofoundafterpediatricinﬂictedTBI
and after pediatric hypoxic-ischemic brain injury suggesting
prolonged axonal damage.
3.3.4. Glial Fibrillary Acidic Protein. Glial ﬁbrillary acidic
protein (GFAP) is an essential cytoskeletal protein of astro-
cytes. GFAP does not seem to be found outside the central
nervous system, and, unlike S100B, when GFAP is found in
the CSF or serum, it is likely to be due to cellular damage
and not secretion [125] .I no n es t u d y ,G F A Pl e v e l si nt h e
serum and CSF were elevated in children with severe TBI. In
addition, serum GFAP levels on day 1 postinjury correlated
with functional outcome at 6 months and those patients
treated with therapeutic hypothermia for TBI did not have
signiﬁcantly diﬀerent levels as compared to those treated
with normothermia [126].
Examples of commonly used biomarker blood tests in
clinical medicine include troponin and brain natriuretic
peptide (BNP) in cardiac disease. Unfortunately, the clinical
study of biomarkers for TBI in children are limited and
even the most frequently studied biomarkers (S100 calcium
binding protein B, neuron-speciﬁc enolase, myelin binding
protein) are not currently standard measurement for pedi-
atric TBI. While all of these biomarkers have shown some
correlation between concentrations and outcomes, they still
lack the statistical power to be clinically useful. Cerebral
proteomic and metabolomic analyses are an emerging ﬁeld
and, with advancing biotechnology, new biomarkers are
being developed and researchers are using advanced statisti-
cal analysis, such as ﬁnite element modeling and combining
two or more biomarkers with and without collaborating
data, such as neurologic imaging to correlate with outcomes.
The hope is that these advanced biomarkers in the future
will help assess the degree of TBI, tailor therapy, guide
rehabilitation, and aid caregivers, and families in diﬃcult
decisions.
3.3.5. Common Data Elements (CDEs) for Biospecimens.
Pediatric TBI is a global problem, with the World Health
Organization predicting that by the year 2020 TBI will be
the most common cause of death in children. Coordinated
research and strength of evidence-based medicine require
standardization of deﬁnitions and data elements to compare
ﬁndings across studies and facilitate data sharing amongst
institutions [127]. This has recently been extended to
include recommendations for pediatric patients, including
recommendations from an expert panel for best practice
guidelines to standardize the quality and accessibility of
biospecimens for pediatric TBI [128]. While there are no
speciﬁc recommendations regarding speciﬁc biomarkers,
this expert panel does outline guidelines that will allow
for consistency across studies to develop a minimal set of
measures and direction for additional biospecimen collec-
tion for hypothesis-driven studies. Core CDE (minimum)
recommendations include the collection of an acute (<24h
postinjury) serum sample for proteomic and metabolomics
analyses [128]. Supplemental CDE (greater depth and
breadth of exploration) recommendations focus on serial
collection of serum and CSF samples which will allow for
study of injury progression and trajectory, including iden-
tiﬁcation of evolving molecular derangement and eventual
study of molecular-targeted interventions dependent on the
temporal cascade of secondary injury. More controversial is
an extended CDE (emerging study in pediatrics requiring
validation) recommendation for cerebral microdialysis as
a data element [128]. Cerebral microdialysis as described
in previous sections has not been universally adopted in
pediatric TBI; however, microdialysis is extensively used in
adult patients as a measure of cerebral metabolism and
cerebralbioenergeticdysfunction.Furtherrecommendations
focus on the speciﬁcs of biospecimen collection, processing,
documentation,andstorage.Intheemergingﬁeldofcerebral
biomarkers of injury, a common vernacular and scientiﬁcally
based analyses will allow clinicians to pool resources and
standardizetheapproachtostudyandinterveneforourmost
at risk patients, pediatric severe TBI.Critical Care Research and Practice 7
4. Conclusion
Neuromonitoring technology is at an “infant” stage in pedi-
atric TBI. While further studies are clearly needed to deter-
mine whether these modalities and advancement in technol-
ogy with noninvasive monitors will allow early and reliable
recognition of reversible secondary brain insults, the ulti-
mate question is whether these new modalities will aid in
treatment strategies that will positively aﬀect outcome.
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